Zager Richard A, Johnson Ali C M
Department of Medicine, University of Washington, and the Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, WA 98109, USA.
Am J Physiol Renal Physiol. 2009 May;296(5):F1032-41. doi: 10.1152/ajprenal.00061.2009. Epub 2009 Mar 4.
Ischemic renal injury can produce chronic renal inflammation and fibrosis. This study tested whether ischemia-reperfusion (I/R) activates histone-modifying enzyme systems and alters histone expression at selected proinflammatory/profibrotic genes. CD-1 mice were subjected to 30 min of unilateral I/R. Contralateral kidneys served as controls. At 1, 3, or 7 days of reflow, bilateral nephrectomy was performed. Renal cortices were probed for monocyte chemoattractant protein-1 (MCP-1), transforming growth factor-beta1 (TGF-beta1), and collagen III mRNAs and cytokine levels. RNA polymerase II (Pol II) binding, which initiates transcription, was quantified at exon 1 of the MCP-1, TGF-beta1, collagen III genes (chromatin immunoprecipitation assay). Two representative gene-activating histone modifications [histone 3 lysine 4 (H3K4) trimethylation (m3) (H3K4m3); histone 2 variant H2A.Z] were sought. Degrees of binding of two relevant histone-modifying enzymes (Set1, BRG1) to target genes were assessed. Renal cortical Set1, BRG1, and H2A.Z mRNAs were measured. Finally, the potential utility of urinary mRNA concentrations as noninvasive markers of these in vivo processes was tested. I/R caused progressive increases in Pol II binding to MCP-1, TGF-beta1, and collagen III genes. Parallel increases in cognate mRNAs also were expressed. Progressive increases in renal cortical Set1, BRG1, H2A.Z mRNAs, and increased Set1/BRG1 binding to target genes occurred. These changes corresponded with: 1) progressive elevations of H3K4m3 and H2A.Z at each test gene; 2) increases in renal cortical TGF-beta1/MCP-1 cytokines; and 3) renal collagen deposition (assessed by histomorphology). Postischemic increases in urinary TGF-beta1, MCP-1, Set1, and BRG1 mRNAs were also observed. We conclude that: 1) I/R upregulates histone-modifying enzyme systems, 2) histone modifications at proinflammatory/profibrotic genes can result, and 3) urinary mRNA assessments may have utility for noninvasive monitoring of these in vivo events.
缺血性肾损伤可导致慢性肾炎症和纤维化。本研究检测了缺血再灌注(I/R)是否激活组蛋白修饰酶系统,并改变选定促炎/促纤维化基因的组蛋白表达。对CD-1小鼠进行30分钟的单侧I/R。对侧肾脏作为对照。在再灌注1、3或7天时,进行双侧肾切除术。检测肾皮质中的单核细胞趋化蛋白-1(MCP-1)、转化生长因子-β1(TGF-β1)、Ⅲ型胶原mRNA和细胞因子水平。在MCP-1、TGF-β1、Ⅲ型胶原基因的外显子1处对启动转录的RNA聚合酶II(Pol II)结合进行定量(染色质免疫沉淀分析)。寻找两种具有代表性的基因激活组蛋白修饰[组蛋白3赖氨酸4(H3K4)三甲基化(m3)(H3K4m3);组蛋白2变体H2A.Z]。评估两种相关组蛋白修饰酶(Set1、BRG1)与靶基因的结合程度。检测肾皮质Set1、BRG1和H2A.Z mRNA。最后,测试尿mRNA浓度作为这些体内过程的非侵入性标志物的潜在效用。I/R导致Pol II与MCP-1、TGF-β1和Ⅲ型胶原基因的结合逐渐增加。同源mRNA也平行增加。肾皮质Set1、BRG1、H2A.Z mRNA逐渐增加,Set1/BRG1与靶基因的结合增加。这些变化与以下情况相对应:1)每个测试基因处H3K4m3和H2A.Z逐渐升高;2)肾皮质TGF-β1/MCP-1细胞因子增加;3)肾胶原沉积(通过组织形态学评估)。缺血后尿中TGF-β1、MCP-1、Set-1和BRG1 mRNA也增加。我们得出结论:1)I/R上调组蛋白修饰酶系统;2)促炎/促纤维化基因处可发生组蛋白修饰;3)尿mRNA评估可能有助于对这些体内事件进行非侵入性监测。